Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash at Sierra Avenue and Karen Lane


2 Vehicles Collide in Fatal Jurupa Valley Accident 

Jurupa Valley, CA (March 23, 2020) – One person was killed in a crash in Jurupa Valley. The fatal accident occurred on the morning of March 23 at Sierra Avenue and Karen Lane.

Two vehicles collided at the intersection for unknown reasons. A man died at the accident scene. Another man was trapped inside his vehicle. He was rescued and taken to a local hospital with minor injuries.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Jurupa Valley

#92509


March 17, 2020

Pedestrian Killed in Crash on Interstate 5 Near Cesar E. Chavez Parkway

Victim Hit by Several Vehicles in Fatal San Diego Accident ...


April 20, 2020

Woman Killed in Crash at Avenal Cutoff Road and 30th Avenue

Car, Truck Collide Head-on in Fatal Kettleman City Accident...


December 17, 2019

1 Killed, 1 Injured in Pedestrian Crash on Santa Fe Drive

Victims Hit by Vehicle in Fatal Atwater Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.